Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TriaGen Wealth Management LLC bought a new position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,109 shares of the medical research company’s stock, valued at approximately $302,000. A number of other large investors have […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target increased by Stifel Nicolaus from $75.00 to $85.00 in a research note published on Wednesday, The Fly reports. Several other brokerages also recently weighed in on EXAS. Piper Sandler increased their price target on Exact Sciences from $50.00 to $70.00 and gave the stock a […]
Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research report released on Wednesday morning, The Fly reports. The firm currently has $85.00 price objective on the medical research company’s stock, up from their previous price objective of $55.00. Other equities research analysts […]
With U.S. stock markets set to open in two hours, Celsius Holdings Inc. (CELH) was up 10.2% in pre-market trading, and Exact Sciences Corp. (EXAS) was up 8.2%.
Exact Sciences (NASDAQ:EXAS – Get Rating) posted its quarterly earnings data on Tuesday. The medical research company reported ($0.42) earnings per share for the quarter, topping the consensus estimate of ($0.79) by $0.37, Briefing.com reports. Exact Sciences had a negative return on equity of 19.76% and a negative net margin of 29.92%. The business had […]